Clinical Trials Browser

Phase 2 × Pituitary ACTH Hypersecretion × Rosiglitazone × Clear all

NCT00612066 2020-08-06

Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease)

Phase 2 Terminated

2 enrolled 5 charts

Pituitary ACTH Hypersecretion